invega sustenna 150 mg / 1.5 ml i.m. prefilled syringe
انفيجا سوستينا 150مجم/1.5مل سرنجة معبأة للحقن العضل
paliperidone · 150 mg / 1.5 ml
4700EGP
- Active ingredient
- paliperidone
- Strength
- 150 mg / 1.5 ml
- Form
- syringe
- Manufacturer
- alza corporation-usa > janssen cilag
- Route
- injection
Uses
Used for treatment of schizophrenia and schizoaffective disorder.
Do not use if
Contraindicated in patients with hypersensitivity to paliperidone, risperidone, or formulation components.
Side effects
Weight gain, insomnia, somnolence, tremor, tachycardia, and extrapyramidal symptoms may occur.
Warnings
Not approved for dementia-related psychosis. Monitor for metabolic effects and neuroleptic malignant syndrome.
How it works
Atypical antipsychotic that acts mainly through dopamine D2 and serotonin 5-HT2A receptor antagonism.
Storage
Store at 20–25°C and protect from moisture.